Literature DB >> 25262636

The effect of pulsatile cardiopulmonary bypass on lung function in elderly patients.

Gerwin E Engels1, Mikhail Dodonov, Gerhard Rakhorst, Willem van Oeveren, Aldo D Milano, Y John Gu, Giuseppe Faggian.   

Abstract

PURPOSE: Cardiopulmonary bypass is still a major cause of lung injury and delay in pulmonary recovery after cardiac surgery. Although it has been shown that pulsatile flow induced by intra-aortic balloon pumping is beneficial for preserving lung function, it is not clear if the same beneficial effect can be accomplished with pulsatile flow generated in the extracorporeal circuit. Therefore, we investigated the effect of pulsatile flow, produced by a centrifugal pump, on lung function in elderly patients.
METHODS: Serial measurements of lung biomarkers Clara cell 16 kD protein, surfactant protein D, and elastase were performed on blood samples from 37 elderly patients (≥75 years) who underwent elective aortic valve replacement surgery with CPB, either with pulsatile perfusion or continuous perfusion. Pulmonary function was assessed by postoperative ventilation time, the arterial blood oxygenation (PaO2/FiO2), the alveolar-arterial oxygen gradient (Aa-O2 gradient) and the pulmonary vascular resistance indexed by body surface area (PVRi).
RESULTS: There was no difference in lung function between both groups, as assessed by the postoperative ventilation time, the PaO2/FiO2 ratio, and the Aa-O2 gradient. The PVRi, however, was significantly lower in the pulsatile perfusion group 15 mins after the administration of protamine (p<0.05). The plasma concentrations of the lung biomarkers increased during surgery and peaked at 1 h ICU, there were however no differences between groups.
CONCLUSIONS: Pulsatile flow does not seem beneficial to postoperative lung function in elderly patients. Moreover, pulsatile flow does not affect lung function on a subclinical level as assessed by lung biomarkers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25262636     DOI: 10.5301/ijao.5000352

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  4 in total

1.  Efficacy of Xuebijing Injection () on Cardiopulmonary Bypass-Associated Pulmonary Injury: A Prospective, Single-center, Randomized, Double Blinded Trial.

Authors:  Wei Gao; Na Li; Xiao-Guang Cui
Journal:  Chin J Integr Med       Date:  2018-07-31       Impact factor: 1.978

Review 2.  Biomarkers of lung injury in cardiothoracic surgery.

Authors:  Gerwin Erik Engels; Willem van Oeveren
Journal:  Dis Markers       Date:  2015-03-17       Impact factor: 3.434

3.  Efficacy of Pulsatile Flow Perfusion in Adult Cardiac Surgery: Hemodynamic Energy and Vascular Reactivity.

Authors:  Mikhail Dodonov; Francesco Onorati; Giovanni Battista Luciani; Alessandra Francica; Maddalena Tessari; Tiziano Menon; Leonardo Gottin; Aldo Domenico Milano; Giuseppe Faggian
Journal:  J Clin Med       Date:  2021-12-17       Impact factor: 4.241

Review 4.  Pulmonary Complications of Cardiac Surgery.

Authors:  Tristan George Tanner; Mai O Colvin
Journal:  Lung       Date:  2020-11-11       Impact factor: 2.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.